Analysis of relationship between autoimmune response and, structure and function of proteasome-PCNA multiprotein complex
Analysis of relationship between autoimmune response and, structure and function of proteasome-PCNA multiprotein complex
批准号:
16590995
负责人:
TAKASAKI Yoshinari
金额:
$1.15万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We have previously shown that a group of anti-PCNA monoclonal antibodies (mAbs) raised in our laboratory can react with PCNA bound to or interacting with other proteins associated with cell proliferation (PCNA complexes). In addition, we have found that proteasome is also interacting with PCNA and showed that the proteasome interacting with PCNA is the hybrid-type proteasome consisted of PA700, 20S proteasone and PA28(γ). We then analyzed autoimmune response of proteins in the proretasome in patients with various connective tissue disease, and found that 24% of sera from patients with systemic lupus erythematosus (SLE) and 13% of sera from Sjogren's syndrome (SjS) reacted with PA28γ, whereas 26% of lupus sera and 23% of sera from SjS reacted with PA28α. These results suggested that autoantigens targeted by SLE and SjS are different although both two proteins are the same components of proteasome. We also found that the occurrence of the autoimmune response to these proteins had a significant linkage. To analyze the mechanisms of the linkage, we tested autoimmune response to the components of 20S proteasome that is interacting with both two proteins. Then, we found that the frequency of antibodies to PA28αand PA28γ became three times higher if the sera were reactive with α subunit of 20S proteasome. In addition, a linkage of autoimmune response between PCNA and proteasome was also shown, and the frequency of antibodies to PCNA increased 10 times higher among those sera. Taken together, these findings suggest that "antige presentation" is playing a critical role to induce the autoimmune response to the PCNA complex including proteasome.
期刊论文(34)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1007/s10165-004-0325-2
发表时间:
2004-01-01
期刊:
Modern rheumatology
影响因子:
2.2
作者:
[Takasaki, Yoshinari, Yamanaka, Kenjiro, Hashimoto, Hiroshi]
通讯作者:
Hashimoto, Hiroshi
DOI:
10.1093/intimm/dxh131
发表时间:
2004-09
期刊:
International immunology
影响因子:
4.4
作者:
[Y. Takasaki;K. Kaneda;M. Matsushita;Hirofumi Yamada;M. Nawata;R. Matsudaira;M. Asano;R. Mineki;N. Shindo;H. Hashimoto]
通讯作者:
Y. Takasaki;K. Kaneda;M. Matsushita;Hirofumi Yamada;M. Nawata;R. Matsudaira;M. Asano;R. Mineki;N. Shindo;H. Hashimoto
Glyleraldehyde 3-phosphate dehydrogenase is a novel autoantigen leading autoimmune responses to proliferating cell nuclear antigen nuclear antigen multiprotein complexs in lupus patients.
甘油醛 3-磷酸脱氢酶是一种新型自身抗原,可导致狼疮患者对增殖细胞核抗原核抗原多蛋白复合物产生自身免疫反应。
DOI:
--
发表时间:
2004
期刊:
lnt Immunol 16
影响因子:
--
作者:
[Takasaki Y, Kaneda K, Matsushita M, Yamada H, et al.]
通讯作者:
et al.
Autoimmune response to proteasome activator 28α in patients with connective tissue diseases.
结缔组织疾病患者对蛋白酶体激活剂 28α 的自身免疫反应。
DOI:
--
发表时间:
2004
期刊:
J.Rheumatol 31
影响因子:
--
作者:
[Matsushita M, Takasaki Y, Takeuchi K, et al.]
通讯作者:
et al.
Autoimmune response to proteins of proliferating cell nuclear antigen (PCNA) multiprotein complexes in patients with connective tissue diseases
结缔组织疾病患者对增殖细胞核抗原(PCNA)多蛋白复合物的自身免疫反应
DOI:
--
发表时间:
2004
期刊:
J.Rheumatol 31
影响因子:
--
作者:
[Kaneda k, Takasaki Y, Takeuchi K, et al.]
通讯作者:
et al.
共 11 条
Effect of SLAM mutation and activating and inhibitory FcR on autoimmune prone mice
-
批准号:26461474
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.16万
-
财政年份:2014
-
负责人:TAKASAKI Yoshinari
-
依托单位:
Association of linkage between autoantigens and, ubiquitin. proteasome system in autoantibody production
-
批准号:21591271
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2009
-
负责人:TAKASAKI Yoshinari
-
依托单位:
Analysis of structure of proteasome-PCNA multiprotein conplex and its autoimmune response
-
批准号:13670476
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.47万
-
财政年份:2001
-
负责人:TAKASAKI Yoshinari
-
依托单位:
Analysis of a novel RNA epitope recognized by sera in patients with rheumatic diseases using randomized RNA epitope library
-
批准号:10670427
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.22万
-
财政年份:1998
-
负责人:TAKASAKI Yoshinari
-
依托单位:
Epitopes on Ki antigen and its association to autoantibody production.
-
批准号:04670396
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1992
-
负责人:TAKASAKI Yoshinari
-
依托单位:
国内基金
海外基金
登录
查看更多内容
宿主细胞DNAJA4蛋白受LMBV PCNA招募对
病毒复制影响及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:李蔚
-
依托单位:
hMOF 调控PCNA蛋白乙酰化及表达影响卵巢癌细胞对铂类药物敏感性的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:徐苏龙
-
依托单位:
幽门螺杆菌通过USP1/PCNA分子轴介导的有氧糖酵解促进胃癌恶性进展的作用和机制研究
-
批准号:2025JJ80837
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:白飞
-
依托单位:
DTX1 通过泛素化降解 PCNA 调控肝癌细胞增殖的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2024
-
负责人:封奕
-
依托单位:
TM9SF1调控FEN1/PCNA运输的分子机制及临床应用研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
BRS3 激动剂基于 P21/PCNA 通路介导肾损伤后修复机制研究
-
批准号:2024JJ7444
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:彭亮
-
依托单位:
PCNA/DHX9/R-loop轴增强奥沙利铂诱导胃癌免疫原性细胞死亡的分子机制研究
-
批准号:82373123
-
项目类别:面上项目
-
资助金额:48万元
-
批准年份:2023
-
负责人:陶凯雄
-
依托单位:
ROS介导的PCNA次磺酸化修饰在肿瘤中的作用和机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:王魁
-
依托单位:
PCNA相关重组抑制剂介导的DNA修复过程对结肠癌细胞微环境和葡萄糖代谢的影响及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:
-
依托单位:
具核梭杆菌调控AJUBA浆/核分布与PCNA直接互作促进喉鳞癌恶性增殖的机制研究
-
批准号:82273097
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:张明
-
依托单位: